Evidence map›Paper›PMID 35906340›Full record

ArticleClinical oral investigations2022

Association of periodontal therapy, with inflammatory biomarkers and complications in COVID-19 patients: a case control study.

Khalid N Said, Ahmed M Al-Momani, Jassim A Almaseeh, Nadya Marouf, Amer Shatta, Jassim Al-Abdulla, Sahar Alaji, Hanin Daas, Shailaja S Tharupeedikayil, Venkateswara Rao Chinta and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Khalid N SaidDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Ahmed M Al-MomaniDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Jassim A AlmaseehDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Nadya MaroufDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Amer ShattaDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Jassim Al-AbdullaDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Sahar AlajiDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Hanin DaasCollege of Dental Medicine, QU Health, Qatar University, Doha, Qatar.
Shailaja S TharupeedikayilDepartment of Dentistry and Oral Health Institute, Hamad Medical Corporation, Doha, Qatar.
Venkateswara Rao ChintaDepartment of Business Intelligence, Hamad Medical Corporation, Doha, Qatar.
Ali Ait HssainMedical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.
Mohammad AbusamakFaculty of Dentistry, McGill University, Montreal, Canada.
Shiraz SalihCollege of Dental Medicine, QU Health, Qatar University, Doha, Qatar.
Noha BarhomCollege of Dental Medicine, QU Health, Qatar University, Doha, Qatar.
Wenji CaiFaculty of Dentistry, McGill University, Montreal, Canada.
Mariano SanzFaculty of Odontology, ETEP Research Group, Universidad Complutense de Madrid, Madrid, Spain.
Faleh TamimiCollege of Dental Medicine, QU Health, Qatar University, Doha, Qatar. fmarino@qu.edu.qa.ORCID http://orcid.org/0000-0002-4618-8374
Hamad Medical Corporation · QAQatar University · QAMcGill University · CAUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn previous studies, COVID-19 complications were reported to be associated with periodontitis. Accordingly, this study was designed to test the hypothesis that a history of periodontal therapy could be associated with lower risk of COVID-19 complications.

methodsA case-control study was performed using the medical health records of COVID-19 patients in the State of Qatar between March 2020 and February 2021 and dental records between January 2017 and December 2021. Cases were defined as COVID-19 patients who suffered complications (death, ICU admissions and/or mechanical ventilation); controls were COVID-19 patients who recovered without major complications. Associations between a history of periodontal therapy and COVID-19 complications were analysed using logistic regression models adjusted for demographic and medical factors. Blood parameters were compared using Kruskal-Wallis test.

resultsIn total, 1,325 patients were included. Adjusted odds ratio (AOR) analysis revealed that non-treated periodontitis was associated with significant risk of need for mechanical ventilation (AOR = 3.91, 95% CI 1.21-12.57, p = 0.022) compared to periodontally healthy patients, while treated periodontitis was not (AOR = 1.28, 95% CI 0.25-6.58, p = 0.768). Blood analyses revealed that periodontitis patients with a history of periodontal therapy had significantly lower levels of D-dimer and Ferritin than non-treated periodontitis patients.

conclusionAmong COVID-19 patients with periodontal bone loss, only those that have not received periodontal therapy had higher risk of need for assisted ventilation. COVID-19 patients with a history of periodontal therapy were associated with significantly lower D-dimer levels than those without recent records of periodontal therapy. CLINICAL RELEVANCE: The fact that patients with treated periodontitis were less likely to suffer COVID-19 complications than non-treated ones further strengthen the hypothesis linking periodontitis to COVID-19 complications and suggests that managing periodontitis could help reduce the risk for COVID-19 complications, although future research is needed to verify this.

Indexed as

Alveolar Bone LossCOVID-19PeriodontitisBiomarkersCase-Control StudiesHumansBiomarkersCOVID-19D-dimerPeriodontal diseasePeriodontal therapyPeriodontitis

Identifiers

PMID35906340
PMCPMC9643194
OpenAlexW4288713710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.